BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19630272)

  • 21. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
    Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
    J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone-induced hepatomegaly and steatosis in larval zebrafish.
    Yin G; Cao L; Du J; Jia R; Kitazawa T; Kubota A; Teraoka H
    J Toxicol Sci; 2017; 42(4):455-459. PubMed ID: 28717104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
    Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
    J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way.
    Marmugi A; Lukowicz C; Lasserre F; Montagner A; Polizzi A; Ducheix S; Goron A; Gamet-Payrastre L; Gerbal-Chaloin S; Pascussi JM; Moldes M; Pineau T; Guillou H; Mselli-Lakhal L
    Toxicol Appl Pharmacol; 2016 Jul; 303():90-100. PubMed ID: 27180240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction.
    Vispute SG; Bu P; Le Y; Cheng X
    Toxicology; 2017 Mar; 378():95-106. PubMed ID: 28088388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis.
    Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H
    Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation.
    Lettéron P; Brahimi-Bourouina N; Robin MA; Moreau A; Feldmann G; Pessayre D
    Am J Physiol; 1997 May; 272(5 Pt 1):G1141-50. PubMed ID: 9176224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E47 modulates hepatic glucocorticoid action.
    Hemmer MC; Wierer M; Schachtrup K; Downes M; Hübner N; Evans RM; Uhlenhaut NH
    Nat Commun; 2019 Jan; 10(1):306. PubMed ID: 30659202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.
    Spitler KM; Ponce JM; Oudit GY; Hall DD; Grueter CE
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H768-H780. PubMed ID: 28159809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisomal beta-oxidation and steatohepatitis.
    Rao MS; Reddy JK
    Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1.
    Li K; Zhao B; Wei D; Wang W; Cui Y; Qian L; Liu G
    Int J Mol Med; 2020 Feb; 45(2):543-555. PubMed ID: 31894315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male Rats.
    Gadupudi GS; Klaren WD; Olivier AK; Klingelhutz AJ; Robertson LW
    Toxicol Sci; 2016 Jan; 149(1):98-110. PubMed ID: 26396156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The responses of rat liver glucocorticoid receptors and genes for tyrosine aminotransferase, alpha-2-macroglobulin and gamma-fibrinogen to adrenalectomy-, dexamethasone- and inflammation-induced changes in the levels of glucocorticoids and proinflammatory cytokines.
    Sevaljević L; Isenović E; Vulović M; Macvanin M; Zakula Z; Kanazir D; Ribarac-Stepić N
    Biol Signals Recept; 2001; 10(5):299-309. PubMed ID: 11490095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone facilitates lipid accumulation and mild feed restriction improves fatty acids oxidation in skeletal muscle of broiler chicks (Gallus gallus domesticus).
    Wang X; Lin H; Song Z; Jiao H
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 May; 151(4):447-54. PubMed ID: 20138241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Deletion of the Glucocorticoid Receptor in Hepatocytes Disrupts Postprandial Lipid Metabolism in Male Mice.
    Correia CM; Præstholm SM; Havelund JF; Pedersen FB; Siersbæk MS; Ebbesen MF; Gerhart-Hines Z; Heeren J; Brewer J; Larsen S; Blagoev B; Færgeman NJ; Grøntved L
    Endocrinology; 2023 Aug; 164(10):. PubMed ID: 37610219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice.
    Kelly DM; Nettleship JE; Akhtar S; Muraleedharan V; Sellers DJ; Brooke JC; McLaren DS; Channer KS; Jones TH
    Life Sci; 2014 Jul; 109(2):95-103. PubMed ID: 24953607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.